Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients | Scientific Reports
NF-κB in the New Era of Cancer Therapy: Trends in Cancer
PDF] Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. | Semantic Scholar
Nuclear Factor Kappa B Pathway and human cancer therapeutics
The nuclear factor-kappa B pathway and response to treatment in breast cancer | Pharmacogenomics
Carotenoid derivatives inhibit nuclear factor kappa B activity in bone and cancer cells by targeting key thiol groups - ScienceDirect
P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa | SpringerLink
PDF) Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism | Narayan Mandal - Academia.edu
NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews Immunology
DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression
Cancers | Free Full-Text | NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB | HTML
IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer | HTML
Phosphorylation of NF-κB in Cancer | IntechOpen
Nuclear Factor Kappa-B: Bridging Inflammation and Cancer | 2 | Gene Re